Comparison of Standard and Extended Dexamethasone Duration on Mortality in Patients with Severe COVID-19
The results show that extended duration of dexamethasone compared with standard duration is associated with a significant increase in in-hospital mortality in patients with severe COVID-19. These findings need to be confirmed in well-designed and performed randomized controlled trials.
Authors
- Marc Lozano
- Andrew Sephien (ORCID: https://orcid.org/0000-0002-9945-3549)
- Sean-Patrick Prince (ORCID: https://orcid.org/0000-0003-0140-8043)
- Nishant Nerella
- Guarav Shah (ORCID: https://orcid.org/0000-0002-7039-9745)
- Caroline Minton
- Denisse Camille Dayto (ORCID: https://orcid.org/0000-0002-0377-7021)
- Ambuj Kumar (ORCID: https://orcid.org/0000-0003-1260-6694)
Institutions
- Rutgers, The State University of New Jersey (US)
- HCA Healthcare (US)
- Jackson Memorial Hospital (US)
- Data Management (Italy) (IT)
Publication Details
- Journal
- Southern Medical Journal
- Published
- 2024-12-01
- DOI
- https://doi.org/10.14423/smj.0000000000001760
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39